Liprotek

PETROLATUM, LIDOCAINE TOPICAL HUMAN OTC DRUG

Liprotek is an FDA drug label for the active ingredient PETROLATUM, LIDOCAINE manufactured by Unit Dose, Ltd. administered by TOPICAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231019.

Generic name
PETROLATUM, LIDOCAINE
Manufacturer
Unit Dose, Ltd.
Product type
HUMAN OTC DRUG
Route
TOPICAL
Dosage form
N/A
NDC
67194-017
Application
M017
Label effective
20231019

Active ingredients

Active Ingredient Petrolatum (white) 61% Lidocaine 0.6% PURPOSE Skin Protectant External or Topical Analgesic

Indications & Usage

Uses: TEMPORARY RELIEF OF PAIN AND/OR ITCHING FROM FEVER BLISTERS AND COLD SORES

Dosage & Administration

Uses: TEMPORARY RELIEF OF PAIN and/or ITCHING FROM FEVER BLISTERS and COLD SORES

Contraindications

Not available.

Warnings

WARNING: Keep away from children. Do not use if allergic tp any of the ingredients. If condition worsens or if symptoms persist for more than 7 days or clear up and occur again within a few days then discontinue use of this product and cunsult a doctor.

Adverse Reactions

Not available.

More products with the same ingredient

PETROLATUM, LIDOCAINE

Numstick

Unit Dose, Ltd. View label